Concord Biotech Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	-	9.05	151.42	34.99	6.67	51.44
Short-Term Investments	-	179.89	228.22	305.8	872.5	550
Trading Asset Securities	-	3,165	2,437	1,369	734.73	1,410
Cash & Short-Term Investments	3,314	3,354	2,817	1,710	1,614	2,011
Cash Growth	16.78%	19.09%	64.71%	5.96%	-19.76%	0.31%
Accounts Receivable	-	5,217	3,496	2,738	2,322	1,775
Other Receivables	-	210.46	193.66	217.95	272.74	358.19
Receivables	-	5,427	3,690	2,956	2,594	2,133
Inventory	-	2,397	2,080	2,123	1,951	1,536
Prepaid Expenses	-	73.91	73.31	55.19	47.61	45.44
Other Current Assets	-	100.48	303.06	433.05	119.5	345.27
Total Current Assets	-	11,352	8,962	7,277	6,327	6,071
Property, Plant & Equipment	-	8,442	7,865	7,655	6,436	5,577
Long-Term Investments	-	227.81	20.7	79.25	2.56	3.66
Other Intangible Assets	-	11.22	3.2	1.98	35.77	64.18
Other Long-Term Assets	-	308.86	156.1	126.8	327.4	108.69
Total Assets	-	20,343	17,007	15,140	13,128	11,825
Accounts Payable	-	1,130	944.35	938	831.06	463.97
Accrued Expenses	-	192.07	168.21	146.19	131.45	102.38
Short-Term Debt	-	3.81	-	-	43.37	50.99
Current Portion of Long-Term Debt	-	-	62.3	250	250	250
Current Portion of Leases	-	19.58	16.21	1.47	15.96	13.01
Current Income Taxes Payable	-	101.27	54.94	89.99	-	-
Current Unearned Revenue	-	-	-	13.13	32.72	-
Other Current Liabilities	-	393.5	175.55	479.67	247.1	177.04
Total Current Liabilities	-	1,841	1,422	1,918	1,552	1,057
Long-Term Debt	-	-	-	62.36	312.49	562.5
Long-Term Leases	-	6.3	18.87	1.64	3.11	16.33
Long-Term Deferred Tax Liabilities	-	340.22	280.65	234.39	209.71	174.53
Other Long-Term Liabilities	-	28.2	19.56	22.97	18.74	20.98
Total Liabilities	-	2,215	1,741	2,240	2,096	1,832
Common Stock	-	104.62	104.62	104.62	95.11	95.11
Additional Paid-In Capital	-	819.71	819.71	819.71	829.22	829.22
Retained Earnings	-	17,203	14,342	11,976	10,108	9,069
Shareholders' Equity	18,268	18,127	15,266	12,900	11,032	9,994
Total Liabilities & Equity	-	20,343	17,007	15,140	13,128	11,825
Total Debt	16.07	29.69	97.38	315.46	624.93	892.83
Net Cash (Debt)	3,298	3,325	2,719	1,395	988.98	1,118
Net Cash Growth	17.64%	22.26%	94.98%	41.02%	-11.58%	-24.66%
Net Cash Per Share	31.32	31.78	25.99	13.33	9.45	10.69
Filing Date Shares Outstanding	106.05	104.62	104.62	104.62	104.62	104.62
Total Common Shares Outstanding	106.05	104.62	104.62	104.62	104.62	104.62
Working Capital	-	9,512	7,541	5,359	4,775	5,014
Book Value Per Share	173.32	173.27	145.93	123.31	105.45	95.53
Tangible Book Value	18,255	18,116	15,263	12,898	10,996	9,930
Tangible Book Value Per Share	173.13	173.17	145.90	123.29	105.11	94.91
Land	-	629.93	547.11	547.11	547.11	546.99
Buildings	-	3,553	2,576	2,463	2,226	1,981
Machinery	-	6,622	4,979	4,788	4,285	3,773
Construction In Progress	-	501.31	2,115	1,727	741.55	179.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.